Does accelerated approval mean the drug is unapproved?

No. It is an FDA approval pathway with specific evidence requirements and possible confirmatory obligations. Forzinity's approval should be described accurately while preserving the narrow population and outcome, rather than dismissing or overstating what it establishes. [1]

What endpoint supported Forzinity's approval?

The label identifies improvement in knee extensor muscle strength, an intermediate clinical endpoint. That is more precise than calling it a generic anti-aging result or substituting an unrelated laboratory biomarker for the measured outcome. [1]

Does the Barth syndrome indication apply to healthy adults?

No. The approved population is defined by Barth syndrome and the labeled weight requirement. It does not establish a general longevity indication or validate every preparation marketed to otherwise healthy people under the SS-31 name. [1]

What should a reader check beyond the molecule name?

Check the product, formulation, approved indication, patient population and label revision. Those details explain what the approval actually covers and help distinguish the finished medicine from research terminology or a seller's broader wellness claim.

Is SS-31 the same as approved Forzinity?

Sipra editorial team

Updated 2026-09-16

SS-31 is a research name associated with elamipretide. Forzinity is a specific FDA-approved elamipretide injection for a defined Barth syndrome population. That approval does not cover every product sold as SS-31 or general longevity use. ^{1, 2}

Forzinity received accelerated approval in 2025 to improve muscle strength in adults and children with Barth syndrome who weigh at least 30 kg. The approval is based on improvement in knee extensor muscle strength, an intermediate clinical endpoint. Continued approval may depend on confirming clinical benefit.

A research-market vial is not the approved product merely because its listing uses elamipretide or SS-31. Identity, manufacturing quality, route, and indication cannot be inferred from a name.

Is Forzinity approved for ordinary fatigue or anti-aging?

Those are not the labeled indication. Evidence and approval for a rare genetic condition should not be generalized to otherwise healthy people.

What does accelerated approval mean?

It is FDA approval through a pathway that can use a surrogate or intermediate clinical endpoint reasonably likely to predict benefit. Continued approval can depend on confirming that benefit in further studies.

Bottom line

Forzinity has a specific product approval and a narrow indication. SS-31 marketing does not inherit either.

Explore peptide evidence and safety

Is SS-31 the same as approved Forzinity?

Is Forzinity approved for ordinary fatigue or anti-aging?

What does accelerated approval mean?

Frequently asked questions

Related questions

Your Privacy Choices

Your Privacy Choices